Robertson discusses the trends shaping the future of oncology commercialization.
Anne Marie Robertson
Advertisement
Anne Marie Robertson is EVP of EVERSANA Oncology Commercialization.
Articles by Anne Marie Robertson
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Bristol Myers Squibb Discloses Patient Death in CAR-T Multiple Sclerosis Trial
2
Roundup: Teva Acquires BXCL501 for $57.5 Million Upfront, Rumi Therapeutics Enters Option Agreement for Fragile X PDE2 Inhibitor From Enthorin
3
Pathos Ai Enters Drug Development Collaboration with Bristol Myers Squibb and Tempus Ai
4
FDA Extends Talzenna-Xtandi to Hormone-Sensitive Prostate Cancer
5